White Papers

White Papers | June 12, 2020

RWE and Risk: A Primer

Balancing the Demand for Deep Data with Patient Privacy. As pharma companies have become more sophisticated in their use of real-world evidence (RWE), ...

White Papers | June 12, 2020

Avoid the Blur of Data Masking

Learn the difference between data masking and de-identification. Often confused, data masking and de-identification are not synonymous terms when it comes to unlocking protected health information ...

White Papers | June 12, 2020

De-Identification of Unstructured Data

De-identifying Unstructured Data to Enable Health Analytics. According to one organization, 80 percent of medical record data will be unstructured within the next two years.

White Papers | June 12, 2020

Achieving Clinical Trials Transparency

Recent policy changes by Europe’s regulatory authority for drugs and devices has rekindled the pharmaceutical industry’s focus on clinical trials transparency.

White Papers | June 12, 2020

Specialty Pharmaceuticals and Patient Privacy

In the specialty pharmaceutical industry, patient privacy is crucial. Privacy can be a challenge for companies looking to gather and consolidate patient...

1 2 3 4